GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

101

Metastasis Directed Therapy- JAMA Oncol 2026

Metastasis-Directed Therapy (MDT) Overview: MDT refers to localised treatments aimed specifically at metastatic lesions in patients with cancer. These therapies include techniques such as stereotactic body radiotherapy (SBRT),...

102

ACS 2026 Statastical Report

The ACS publishes an annual "Cancer Facts & Figures" report, which provides comprehensive statistics on cancer incidence, survival rates, mortality, and trends in the United States. The report...

103

GEP-NET- Gastroenterology Jan.26

Overview of GEP-NETs Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a subtype of neuroendocrine neoplasms (NENs) that arise from neuroendocrine cells within the gastrointestinal (GI) tract and pancreas. These tumors...

104

T1 CRC and ESD(GIE, Jan-2026)

T1 Colorectal Cancer (CRC) T1 CRC refers to early-stage colorectal cancer where the tumor has invaded the submucosa but has not yet spread further. It is subdivided into...

105

Novel Therapeutic approach for pancreatic cancer(GIE,Jan-2026)

The novel therapeutic approach for pancreatic cancer, as detailed in the study published in Gastrointestinal Endoscopy (GIE), January 2026, involves the combination of intratumoral phosphorus-32 (32P) implantation with...

106

Screening for Esophageal Cancer

Screening for esophageal cancer is a critical strategy to improve early detection and survival rates, given the disease's poor prognosis due to late-stage diagnosis. However, effective screening approaches...

107

Glecirasib with or without Cetuximab in previously treated CRC with KRAS mutation - Lancet Gastroenterol Hepatol

The study published in Lancet Gastroenterology & Hepatology investigates the efficacy and safety of glecirasib (JAB-21822), a novel covalent small molecule KRASG12C inhibitor, as monotherapy or in combination...

108

New Drugs for hepatobiliary Cancers - J of Hepatology - Jan.26

The treatment of hepatobiliary cancers, including hepatocellular carcinoma (HCC) and biliary tract cancer (BTC), is undergoing significant advancements with the development of novel drugs and therapeutic strategies. These...

109

Tumour Microenvironment in ICC

The tumor microenvironment (TME) in intrahepatic cholangiocarcinoma (iCCA) plays a pivotal role in tumor progression, immune evasion, and therapeutic resistance. iCCA is characterized by a highly complex and...

110

Chines Expert Consensus of GIST

The Chinese Expert Consensus on Diagnosis and Treatment of Small Gastrointestinal Stromal Tumors (GISTs) is a comprehensive guideline developed by the CSCO Gastrointestinal Stromal Tumor Committee in collaboration...

Previous
110111217
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer